Zealand gains $100M in funding from Royalty Pharma (RPRX:NASDAQ)
· seekingalpha.com
Royalty Pharma funds Zealand with $100M for rusfertide (PTG-300) royalties in polycythemia vera. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...